June 7 (Reuters) - Teva Pharmaceutical Industries
on Wednesday agreed to pay Nevada $193 million to
settle claims that its marketing practices fueled opioid
addiction, the state announced. Nevada was one of two . | Jun. 07
By Brendan Pierson (Reuters) - Teva Pharmaceutical Industries on Wednesday agreed to pay Nevada $193 million to settle claims that its marketing pract.
(Reuters) - AbbVie Inc's unit Allergan has reached an agreement to pay over $2 billion to resolve thousands of lawsuits related to the marketing of it.